Drug interaction study: does capivasertib alter cholesterol med levels?
NCT ID NCT07088913
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 42 times
Summary
This completed Phase 1 study in 20 healthy adults tested whether taking capivasertib changes how the body absorbs and clears rosuvastatin, a common cholesterol-lowering drug. Participants received rosuvastatin alone and then again with capivasertib, and researchers measured drug levels in the blood. The goal is to understand potential drug interactions, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Baltimore, Maryland, 21225, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
capivasertib and rosuvastatin
What this could lead to
If successful, this could help doctors understand whether capivasertib changes how other drugs work in the body, leading to safer dosing guidelines.
What could go wrong
This is a very early, small study in healthy people, not patients. It only looks at drug levels in the blood, not real-world treatment outcomes or side effects.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.